Status:
COMPLETED
The Effect of IEQ on Cognition and Health
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Environmental Exposure
Temperature Change, Body
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
The goal of this study is to learn about the effect of heat and humidity on cognition and health. The main question\[s\] it aims to answer are: type of study: interventional participant population: 2...
Detailed Description
Overall, the project aims to evaluate the effects of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognition, for longer exposure dura...
Eligibility Criteria
Inclusion
- BMI between 18.5-26 kg/m2
- Age between 20-40 years
- Proficient with the English language in both verbal and written form
- Healthy; no illness or disease or prescribed medication within the last 3 months
- Steady dietary and sleeping habits
- Regularly physically active (i.e., regularly active but less than 3 times a week for less than 2 hours per session at moderate intensity)
- Non-smoker or person who quit smoking more than five years ago
- Reside in the Netherlands (or surrounding countries) for at least 6 months
Exclusion
- Subjects with cardiac problems and cardiovascular diseases, such as angina pectoris, cardiac infarction, and arrhythmias
- Subjects with any medical condition requiring treatment and/or medication (except oral contraceptives) that might interfere with the investigated parameters E.g., Extreme chronotype, colour blindness, epilepsy
- Subjects with a disorder or disease (Parkinson, Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer, diabetes, cardiovascular disorder, respiratory impairments (for example asthma), hypertension, obesity, or any other condition that can impair the lung function), or Raynaud's phenomenon
- Subjects with abnormal diet and sleeping patters and/or abnormal body weight (weight gain or loss \>3kg in the past month)
- Subjects who recently participated in other interventional biomedical study within 1 month prior to screening visit
- Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician will be informed, cannot participate in this study
- Subjects with previous covid infection in the past 3 months or any subject with persistent long covid symptoms that may have caused ongoing loss of or altered sense of smell
- Subjects who had severely altered sleep patterns in the past year
- Subjects employed with night shift work within the past year
- Subjects who consume more than two standard drinks of alcohol per day
- Subjects who consume more than two standard drinks of coffee per day
- Subjects who are pregnant
Key Trial Info
Start Date :
June 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 7 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05972187
Start Date
June 18 2023
End Date
May 7 2024
Last Update
March 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University
Maastricht, Netherlands